{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T06:34:01Z","timestamp":1766990041517,"version":"3.48.0"},"reference-count":35,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The HIV-1 envelope glycoprotein gp120 is prominently exposed on the surface of both HIV-1 virions and infected host cells, serving as a key marker of infection. gp120 plays a pivotal role in viral entry by interacting with the primary receptor, CD4, on host cells. Therapeutic strategies targeting the HIV-1 reservoir, such as anti-gp120 antibodies that trigger antibody-dependent cellular cytotoxicity (ADCC) and chimeric antigen receptor T (CAR-T) cells, rely on the presence of gp120 on the surface of infected cells to exert their effects. Consequently, accurate monitoring of gp120 expression on infected cells is essential for evaluating the pharmacological efficacy of these interventions. In this study, a sensitive, specific, and inexpensive enzyme-linked immunosorbent assay (ELISA) for quantifying HIV-1 gp120 glycoprotein was developed using a selected pair of anti-gp120 antibodies. The assay achieved a lower limit of quantitation (LLOQ) of 0.16 pM, demonstrating sensitivity comparable to that of the digital single molecule array (Simoa) platform, which exhibited a LLOQ of 0.23 pM and requires specialized instrumentation. The binding specificity of the antibodies used in the novel assay was confirmed using liquid chromatography\u2013mass spectrometry (LC-MS), and the assay was pharmacologically validated with lysates obtained from 2D10 and MOLT IIIB cell lines. Furthermore, treatment of HIV-infected human primary CD4+ T cells with a targeted activator of cell kill (TACK) compound significantly reduced gp120 concentration in CD4+ T cell lysate compared to controls. The gp120 marker from infected cell lysates correlated with the number of gp120-positive cells detected by immunocytochemistry, as well as with HIV-1 p24 levels and cell-associated viral RNA measurements. In summary, a novel, simple, and sensitive HIV-1 gp120 ELISA has been developed and validated. This assay holds potential for investigating HIV-1 persistence and evaluating the efficacy of therapeutic agents targeting infected cells.<\/jats:p>","DOI":"10.3390\/v18010046","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T06:25:51Z","timestamp":1766989551000},"page":"46","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of an Ultrasensitive ELISA Assay for Evaluating HIV-1 Envelope Glycoprotein as a Marker for Targeted Activator of Cell Kill"],"prefix":"10.3390","volume":"18","author":[{"given":"Guoxin","family":"Wu","sequence":"first","affiliation":[{"name":"MRL, Merck & Co., Inc., Rahway, NJ 07065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Sardo","sequence":"additional","affiliation":[{"name":"MRL, Merck & Co., Inc., Rahway, NJ 07065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[{"name":"MRL, Merck & Co., Inc., Rahway, NJ 07065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0628-9700","authenticated-orcid":false,"given":"Steven D.","family":"Heron","sequence":"additional","affiliation":[{"name":"MRL, Merck & Co., Inc., Rahway, NJ 07065, USA"},{"name":"Eurofins Professional Scientific Services Mid Atlantic, LLC, Lancaster, PA 17601, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BaoJen","family":"Shyong","sequence":"additional","affiliation":[{"name":"MRL, Merck & Co., Inc., Rahway, NJ 07065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3316-9325","authenticated-orcid":false,"given":"Matthew","family":"Mazur","sequence":"additional","affiliation":[{"name":"MRL, Merck & Co., Inc., Rahway, NJ 07065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"Gorman","sequence":"additional","affiliation":[{"name":"MRL, Merck & Co., Inc., Rahway, NJ 07065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0854-4224","authenticated-orcid":false,"given":"Carl J.","family":"Balibar","sequence":"additional","affiliation":[{"name":"MRL, Merck & Co., Inc., Rahway, NJ 07065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Magliaro","sequence":"additional","affiliation":[{"name":"MRL, Merck & Co., Inc., Rahway, NJ 07065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Leach","sequence":"additional","affiliation":[{"name":"MRL, Merck & Co., Inc., Rahway, NJ 07065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Rush","sequence":"additional","affiliation":[{"name":"MRL, Merck & Co., Inc., Rahway, NJ 07065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5915-9943","authenticated-orcid":false,"given":"Bonnie J.","family":"Howell","sequence":"additional","affiliation":[{"name":"MRL, Merck & Co., Inc., Rahway, NJ 07065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.chom.2020.03.014","article-title":"The biology of the HIV-1 latent reservoir and implications for cure strategies","volume":"27","author":"Cohn","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kobayashi-Ishihara, M., and Tsunetsugu-Yokota, Y. (2024). Post-transcriptional HIV-1 latency: A Promising Target for Therapy?. Viruses, 16.","DOI":"10.3390\/v16050666"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Chou, T.C., Maggirwar, N.S., and Marsden, M.D. (2024). HIV persistence, latency, and cure approaches: Where are we now?. Viruses, 16.","DOI":"10.3390\/v16071163"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Matsuda, K., and Maeda, K. (2024). HIV Reservoirs and Treatment Strategies toward Curing HIV Infection. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052621"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1517\/14728222.2015.1010513","article-title":"HIV-1 gp120 as a therapeutic target: Navigating a moving labyrinth","volume":"19","author":"Charya","year":"2015","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/092986710790514499","article-title":"The gp120 molecule of HIV-1 and its interaction with T cells","volume":"17","author":"Yoon","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/jcm.29.1.142-147.1991","article-title":"Enzyme-linked immunoassay for human immunodeficiency virus type 1 envelope glycoprotein 120","volume":"29","author":"Gilbert","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1089\/aid.2009.0290","article-title":"Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines","volume":"26","author":"Rychert","year":"2010","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1086\/605695","article-title":"HIV-1 Envelope Protein gp120 Is Present at High Concentrations in Secondary Lymphoid Organs of Individuals with Chronic HIV-1 Infection","volume":"200","author":"Santosuosso","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.chembiol.2023.03.003","article-title":"Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120","volume":"30","author":"Richard","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.1038\/ncomms10844","article-title":"Elimination of HIV-1-infected cells by broadly neutralizing antibodies","volume":"7","author":"Bruel","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jnr.22618","article-title":"Decrease in brain soluble amyloid precursor protein \u03b2 (sAPP\u03b2) in Alzheimer\u2019s disease cortex","volume":"89","author":"Wu","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"E7795","DOI":"10.1073\/pnas.1803468115","article-title":"Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir","volume":"115","author":"Das","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","first-page":"13","article-title":"Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion","volume":"45","author":"Takami","year":"1999","journal-title":"Fukushima J. Med. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e92901","DOI":"10.1172\/jci.insight.92901","article-title":"HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversal","volume":"2","author":"Wu","year":"2017","journal-title":"JCI Insight"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC07","volume":"329","author":"Zhou","year":"2010","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1128\/JVI.02213-14","article-title":"Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo","volume":"88","author":"Rudicell","year":"2014","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1128\/JVI.76.14.7293-7305.2002","article-title":"The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120","volume":"76","author":"Sanders","year":"2002","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/jnr.23122","article-title":"Characterization of plasma \u03b2-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer\u2019s disease","volume":"90","author":"Wu","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wu, G., Keller, S.H., Walters, R.T., Li, Y., Kristoff, J., Magliaro, B.C., Zuck, P., Diamond, T.L., Maxwell, J.W., and Cheney, C. (2025). An Immunocytochemistry Method to Investigate the Translationally Active HIV Reservoir. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020682"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jviromet.2012.08.017","article-title":"Simple diffusion-constrained immunoassay for p24 protein with the sensitivity of nucleic acid amplification for detecting acute HIV infection","volume":"188","author":"Chang","year":"2013","journal-title":"J. Virol. Methods"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4155\/bio-2023-0261","article-title":"Immunocapture LC-MS methods for pharmacokinetics of large molecule drugs","volume":"16","author":"Werth","year":"2024","journal-title":"Bioanalysis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"eabn2038","DOI":"10.1126\/scitranslmed.abn2038","article-title":"Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1","volume":"15","author":"Balibar","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40364-024-00658-x","article-title":"Single cell spatial profiling of FFPE splenic tissue from a humanized mouse model of HIV infection","volume":"12","author":"Wu","year":"2024","journal-title":"Biomark. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Wu, G., Cheney, C., Huang, Q., Hazuda, D.J., Howell, B.J., and Zuck, P. (2021). Improved Detection of HIV Gag p24 Protein Using a Combined Immunoprecipitation and Digital ELISA Method. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.636703"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tim.2015.01.013","article-title":"Towards an HIV-1 cure: Measuring the latent reservoir","volume":"23","author":"Bruner","year":"2015","journal-title":"Trends Microbiol."},{"key":"ref_27","first-page":"23","article-title":"Assays to Measure Latency, Reservoirs, and Reactivation","volume":"417","author":"Siliciano","year":"2018","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ebiom.2015.06.019","article-title":"A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals","volume":"2","author":"Procopio","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Laird, G.M., Eisele, E.E., Rabi, S.A., Lai, J., Chioma, S., Blankson, J.N., Siliciano, J.D., and Siliciano, R.F. (2013). Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003398"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.4156","article-title":"Defective proviruses rapidly accumulate during acute HIV-1 infection","volume":"22","author":"Bruner","year":"2016","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1021\/acschembio.2c00515","article-title":"A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells","volume":"17","author":"Moore","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Remnitz, A.D., Hadad, R., Keane, R.W., Dietrich, W.D., and de Rivero Vaccari, J.P. (2025). Comparison of Methods of Detecting IL-1\u03b2 in the Blood of Alzheimer\u2019s Disease Subjects. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020831"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jim.2018.12.005","article-title":"Measurement of IL-21 in human serum and plasma using ultrasensitive MSD S-PLEX\u00ae and Quanterix SiMoA methodologies","volume":"466","author":"Poorbaugh","year":"2019","journal-title":"J. Immunol. Methods"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1038\/s41467-023-42834-x","article-title":"NULISA: A proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing","volume":"14","author":"Feng","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e14621","DOI":"10.1002\/alz.14621","article-title":"Biomarker discovery in Alzheimer\u2019s and neurodegenerative diseases using Nucleic Acid Linked Immuno-Sandwich Assay","volume":"21","author":"Ashton","year":"2025","journal-title":"Alzheimers Dement."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/1\/46\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T06:29:36Z","timestamp":1766989776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/1\/46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["v18010046"],"URL":"https:\/\/doi.org\/10.3390\/v18010046","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,28]]}}}